To hear about similar clinical trials, please enter your email below
Trial Title:
FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype
NCT ID:
NCT05793021
Condition:
Glioblastoma
Conditions: Official terms:
Glioblastoma
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Diagnostic
Masking:
None (Open Label)
Intervention:
Intervention type:
Diagnostic Test
Intervention name:
Blood sample
Description:
Blood sample pre and post surgery to determine the level of FKBP51s protein
Arm group label:
Single arm
Summary:
The aim of this interventional study is to investigate the correlation between Magnetic
Resonance Phenotype and levels of FKBP51s protein pre and post surgery in adult patients
affected by Glioblastoma
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Age >= 18 years
- Diagnosis of Glioblastoma with surgery criteria
- Brain MRI with contrast both pre and post surgery
Exclusion Criteria:
- No availability of radiological documentation
- Glioblastoma diagnosis not confirmed by Histological examination
- Withdrawal of ICF
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Fondazione Policlinico Universitaro "A. Gemelli" IRCCS
Address:
City:
Roma
Zip:
00168
Country:
Italy
Status:
Recruiting
Investigator:
Last name:
Simona Gaudino, MD
Email:
Principal Investigator
Start date:
July 8, 2021
Completion date:
December 31, 2025
Lead sponsor:
Agency:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Agency class:
Other
Source:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05793021
